China (Mainland)
Factory price Integrase Inhibitor 99% Dabigatran (BIBR 953) 211914-51-1 CAS NO.211914-51-1
- Min.Order: 0 Gram
- Payment Terms: L/C
- Product Details
Keywords
- 99% Dabigatran
- 99% Dabigatran
- 99% Dabigatran
Quick Details
- ProName: Factory price Integrase Inhibitor 99% ...
- CasNo: 211914-51-1
- Molecular Formula: C25H25N7O3
- Appearance: white crystalline powder
- Application: use in chemical
- DeliveryTime: within a week
- PackAge: bags
- Port: Shanghai
- ProductionCapacity: 12 Kilogram/Day
- Purity: 99%
- Storage: Kept in a well-closed, light-resistant...
- Transportation: by sea or express
- LimitNum: 0 Gram
- Moisture Content: 0.1%
- Impurity: 0.05%
- Water content: 0%
Superiority
1. Rich experience.
Our company is a professional production leading factory in China in pharmaceutical area of many years, our products have exported to Germany, Spain, UK, USA, Australia, Middle East, and so on other country, and we have got very good feedback from our customers, we had Established long friendly relations of cooperation. High quality, best price!
2. Great quality, purity and favourable.
Good quality is one of our secret success, welcome order the samples, MOQ just 10 grams.
3. Safe and fast delivery.
We have warehouse in Australia, Canada and England, we have large amounts of stock in the warehouse, can ship to you directly from our foreign warehouse! So we can delivery quickly at the very day when receive the payment. And We offer melting powder into liquid service.
4. Good after-sales service.
Details
Dabigatran Medication Anticoagulant Drugs CAS No. 211914-51-1
| Name | Dabigatran |
| Molecular Formula | C25H25N7O3 |
| Molecular Weight | 471.51 |
| CAS Registry Number | 211914-51-1 |
Description:
Dabigatran is an anticoagulant that can be given by mouth from the class of the direct thrombin inhibitors. It is being studied for various uses and in some cases is an alternative to warfarin as the preferred orally "blood thinner" since it doesn't have to be monitored by blood tests while offering similar results in terms of efficacy. There was no specific way to reverse the anticoagulant effect of dabigatran in the event of a major bleeding event at first,unlike warfarin.A dabigatran antidote has been approved by the FDA in 2015.It was developed by the pharmaceutical company Boehringer Ingelheim.